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Abstract
Background: The role of technology in health care delivery has grown rapidly in the last decade. The potential of mobile
telehealth (MTH) to support patient self-management is a key area of research. Providing patients with technological tools that
allow for the recording and transmission of health parameters to health care professionals (HCPs) may promote behavior changes
that result in improved health outcomes. Although for some conditions the evidence of the effectiveness of MTH is clear, to date
the findings on the effects of MTH on diabetes management remain inconsistent.
Objective: This study aims to evaluate an MTH intervention among insulin-requiring adults with diabetes to establish whether
supplementing standard care with MTH results in improved health outcomes—glycated hemoglobin (HbA1c), blood pressure
(BP), health-related quality of life (HRQoL), diabetes self-management behaviors, diabetes health care utilization, and diabetes
self-efficacy and illness beliefs. An additional objective was to explore the acceptability of MTH and patients’ perceptions of,
and experience, using it.
Methods: A mixed-method design consisting of a 9-month, two-arm, parallel randomized controlled trial (RCT) was used in
combination with exit qualitative interviews. Quantitative data was collected at baseline, 3 months, and 9 months. Additional
intervention fidelity data, such as participants’ MTH transmissions and contacts with the MTH nurse during the study, were also
recorded.
Results: Data collection for both the quantitative and qualitative components of this study has ended and data analysis is ongoing.
A total of 86 participants were enrolled into the study. Out of 86 participants, 45 (52%) were randomized to the intervention
group and 36 (42%) to the control group. Preliminary data on MTH training sessions and MTH usage by intervention participants
are presented in this paper. We expect to publish complete study results in 2015.
Conclusions: The range of data collected in this study will allow for a comprehensive evaluation of processes and outcomes.
The early results presented suggest that MTH usage decreases over time and that MTH participants would benefit from attending
more than one training session.
Trial Registration: ClinicalTrials.gov NCT00922376; http://clinicaltrials.gov/ct2/show/NCT00922376 (Archived by WebCite
at http://www.webcitation.org/6Vu4nhLI6).
(JMIR Res Protoc 2015;4(1):e27)   doi:10.2196/resprot.4035
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Introduction
Overview
Diabetes currently affects approximately 366 million people
and this number is expected to increase to 552 million by 2030
[1]. Diabetes care in England is estimated to take up between
5 and 10% of all National Health Service (NHS) expenditures
[2]. The difficulties of living with diabetes, with its complex
regimen and need for behavior change, is challenging, making
good self-management difficult to achieve [3].
Telehealth (TH) offers patients the ability to record
diabetes-related information electronically and transfer this to
their health care professional (HCP), allowing them to be easily
connected over time to HCPs. Using a mobile platform for TH,
referred to as mobile telehealth (MTH), enables a transition
from a health delivery model where monitoring is infrequent
and discrete in clinics, to continuous and potentially nonintrusive
monitoring taking place across locations [4]. TH is believed to
hold the potential to revolutionize care delivery processes by
improving the efficiency and quality of the care [5], enhancing
patient experience and health-related quality of life (HRQoL),
increasing patient confidence in addressing their needs, and
supporting self-management [6]. However, questions remain
as to whether TH technologies will be acceptable and useful
and lead to improved outcomes in all patients [7,8].
Several systematic reviews have examined the impact of TH in
people with diabetes and yielded inconsistent or inconclusive
findings [9-16]. Concerns about the quality of the studies in this
area have been raised and the need for more robust
methodologies emphasized [17-19]. To date, the focus has been
on glycated hemoglobin (HbA1c) as a primary outcome and
patient-reported outcomes have often not been examined [20].
There is also little research on the factors that influence patients’
engagement with the technology, as well as on the process
variables through which TH might impact health outcomes
[21,22].
This study aimed to address some of these gaps in the literature.
The evaluation in this study was informed by the
recommendations made by the Medical Research Council
(MRC) [23]. The MRC recommends that evaluations consist
of several components, including a review of the literature, the
use of theory to guide design and evaluation, and consideration
for both outcomes and process variables. The importance of
assessing intervention fidelity has also been underlined [24], as
has the valuable contribution of qualitative methods to reach a
better understanding of the factors that could help explain study
findings [23].
Study Aims
The aim of this randomized controlled trial (RCT) is to evaluate
the effectiveness of an MTH intervention on adults with
insulin-requiring diabetes. The MTH intervention involved data
transmission, feedback, and education. The intervention will
be examined based on clinical outcomes—HbA1c and blood
pressure (BP)—diabetes health care utilization, HRQoL, and
self-management behaviors. Secondary aims are to assess the
impact of MTH on process variables, including diabetes
self-efficacy and illness beliefs, and to test whether these
mediate the potential effects of the intervention on the outcomes.
Additional aims include the identification of predictors of MTH
usage, the assessment of intervention fidelity, and the
exploration of patients’ experiences with, and perceptions of,
the acceptability of MTH.
Theoretical Framework
The theoretical foundations guiding the concepts used in the
study included Bandura’s social cognitive theory [25],
Leventhal’s model of illness beliefs [26], and Davis’s
Technology Acceptance Model (TAM) [27]. These theories
propose that self-efficacy and illness beliefs influence health
behaviors, and that factors such as perceived usefulness and
perceived ease of use determine technology usage. The key
behavior change techniques involved in the MTH
intervention—self-monitoring with feedback and
education—have been related to changes in self-efficacy [28]
and education has been linked to changes in beliefs [29].
Concepts from the TAM were selected to examine MTH usage
as work using this model has shown that acceptability, which
is determined by perceived usefulness and perceived ease of
use, predicts usage behavior across a range of technologies. The
information technology training provided, and the extent to
which the technology is perceived to interfere in life, are two
further factors shown to be related to technology usage [30,31],
therefore, these factors are also included to address the question
on predictors of MTH usage.
Methods
Ethical Approval and Registration
This study received full ethical approval from the Joint
University College London/University College London
Hospitals (UCL/UCLH) Committees on the Ethics of Human
Research, Committee Alpha (09/H0715/69). The RCT has been
registered with ClinicalTrials.gov (NCT00922376).
Hypotheses
The primary hypothesis is that standard care supplemented with
MTH can achieve greater improvements in HbA1c and BP.
Secondary hypotheses are that the intervention will result in
greater improvements in self-management behaviors, HRQoL,
and psychological well-being compared to standard care. In line
with the theories, we further hypothesize that improvements in
self-efficacy and illness beliefs will determine the change in
health outcomes and that acceptability of MTH, self-efficacy
to use MTH, and adequacy of MTH training will significantly
predict telehealth usage.
Study Design
This study used a mixed-method design including a two-arm
parallel RCT with repeated measurements—baseline, 3 months,
and 9 months—and qualitative exit interviews with patients. A
sequential design was used in that the RCT was conducted prior
to the qualitative study. As such, the qualitative enquiry was
embedded in the quantitative study and aimed to extend and
help elucidate the quantitative findings.
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Sample Size Calculation
A sample of 248 participants (124 participants per group) was
required to detect significant group differences on the primary
outcome, HbA1c, for a two-group and repeated measures design.
These calculations were based on equal group sizes, an attrition
rate of 30%, 80% power to detect differences at the P=.05
significance level (two-sided), with correlations between
measurements of .70, and an effect size of 0.21 standard
deviation units.
Trial Population and Recruitment
Participants were recruited from a diabetes unit in a secondary
care health center in a multi-ethnic East London borough of
Newham. Eligible participants were insulin-requiring adults
with a diagnosis of type 1 or type 2 diabetes whose most recent
HbA1c was above 7.5%. Participants had to be sufficiently
literate and fluent in English to complete the questionnaires and
have telephone conversations with an HCP. Excluded from the
study were people with prior experience using MTH , people
who had not attended the clinic or had an HbA1c test done in
the last 12 months, were pregnant, regularly travelled outside
the UK for 3 weeks or more, required home visits by a district
nurse for blood glucose (BG) monitoring and/or insulin
administration, or had a diagnosis of kidney failure or sickle
cell disease.
Consent
Participants with an appointment in the following 2 weeks were
screened for eligibility and sent an information sheet, an
invitation to take part, and an interest form. Participants who
did not refuse the invitation were approached on the day of their
appointment when the nature and implications of the research
were explained. Potential participants were given time to
consider participating in the study and those that were willing
to take part were invited to sign a consent form for the RCT.
Upon completion of the 9-month RCT, separate recruitment
materials were sent to the intervention group participants to
inform them about, invite them to, and obtain consent for, the
qualitative interviews.
Baseline Assessment
Each participant was given the opportunity to complete the
questionnaires with a researcher at the clinic or at home (with
assistance, if required) using a prestamped envelope for return
by postal mail.
Randomization
Randomization occurred after the return of the baseline
questionnaire. It was carried out in blocks of 20 participants
using an online sequence generator. All participants were sent
a letter informing them of the group they were allocated to, and
intervention participants were telephoned to confirm the next
steps. General practitioners were notified of their patients’
involvement in the study and allocation group.
The Mobile Telehealth Intervention
Overview of the Mobile Telehealth Equipment and App
The MTH system assessed in this study was developed by a
team of engineers in Oxford, England. Its design was based on
earlier data transmission and diary apps, HCP advice, and user
feedback, and designed according to criteria of ease of use,
personalization, prompt feedback, integration to the user’s
lifestyle, and quality of care [32]. The MTH equipment consisted
of a mobile phone (Sony Ericsson k810i) with MTH app
software installed, charger, BG meter, BP monitoring device,
and Bluetooth cradle. Figure 1 represents the architecture of the
MTH system. The MTH app allows for the recording of several
health parameters: BG and BP readings, time since last meal,
level of physical activity performed so far that day, insulin dose,
and weight. BG and BP were transmitted via Bluetooth and the
remaining data were manually entered using the mobile phone
keyboard. The MTH app could store up to 500 clinical readings,
and both single and bulk data transfers from the mobile phone
to the Web server were possible. Following data recording or
transfer, immediate color-coded graphical feedback was
displayed on the mobile phone screen. This included
representations of (1) the last BG reading recorded in
comparison to the average BG reading for the last month, (2) a
histogram of the frequency of BG readings within different
glycaemic ranges in the last month (see ranges for glycaemic
states below), and (3) scatter plots of the BG and BP readings
recorded in the last 5 days. More sophisticated graphical
representations of the data transferred were available via a
password-protected Web account interface. Color codes
represented different glycemic states: blue for hypoglycemia
(0-4 mmol/L), green for normoglycemia (4-10 mmol/L), amber
for borderline hyperglycemia (10-12 mmol/L), and red for
hyperglycemia (above 12 mmol/L).
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Figure 1. Architecture of the MTH system evaluated.
Intervention Group Protocol
In addition to receiving standard care, intervention participants
were provided with the MTH equipment and a BG strip
prescription letter for the BG meter. Equipment was delivered
to their home by an engineer who trained them to use it. Training
sessions ended when a participant was able to collect, enter,
and transfer data correctly alone. On this occasion, participants
were encouraged to continue to self-monitor at the frequency
recommended by their HCP, and to transfer all data at every
self-monitoring occasion. Weekly BP self-monitoring was
recommended for participants for whom BP monitoring had
not been prescribed prior to the study. Participants in the habit
of relying on their BG meter for a list of readings to show their
HCP were asked to attend their routine clinical appointments
with the MTH mobile phone. The mobile phone could display
a list of date- and time-stamped clinical readings. Alternatively,
HCPs at the clinic where recruitment took place had authorized
access to participants’ MTH data via a Web interface.
The intervention protocol included the MTH nurse completing
the following actions:
1. Making introductory phone calls within 2 weeks of
participants receiving MTH training to introduce herself,
confirm contact details, and collect basic information on diabetes
management.
2. Making 6 weekly educational calls to deliver diabetes
education. In the absence of patient-designated questions, the
following topics could be covered: recognizing and managing
hypoglycemia, aspects of lifestyle management in relation to
alcohol, weight, smoking, food choices, physical activity, illness
and diabetes, and insulin, as well as methods to optimize future
diabetes routine appointments.
3. Responding to participants’ BG and BP readings. BG
readings varied according to participants’ diagnoses (type 1 or
2) and medication (insulin and oral, or insulin only). Participants
with one isolated hypoglycemic event were red-flagged for
closer monitoring for 72 hours. The MTH nurse contacted
participants with a borderline hyperglycemic reading and with
recurring hyperglycemic and hypoglycemic events within 72
hours to assess the reasons for these low/high BG readings.
Recurring hyperglycemia due to illness or medication changes
was red-flagged for 24 hours for closer observation. Those with
sufficient experience with insulin adjustments were encouraged
to titrate their insulin dosage. Those who required a medication
review were asked to schedule an appointment at the clinic. In
more urgent situations (eg, possible ketoacidosis), the MTH
nurse was required to advise the patient to visit an accident and
emergency department. Education and reminders as to the
importance of medication/lifestyle factors in the management
of diabetes were to be provided as appropriate.
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The MTH nurse was required to contact patients with four
consecutive BP readings over 140/80 in a 14-day period to
discuss medication and provide advice on lifestyle changes to
improve BP. If a further four readings above 140/80 in a 14-day
period occurred following a discussion with the participant on
medication and lifestyle changes, the MTH nurse was required
to refer the participant to a general practitioner.
The technical support team provided telephone support,
organized a home visit where appropriate, and contacted
participants who had not transmitted data for more than 7 days.
A maximum of three successful telephone calls were made to
encourage data transmission.
Control Group
Participants in this group received standard care that consisted
of a 30-minute appointment with a diabetes specialist nurse
every 3 to 4 months, and 1 annual or 2 semiannual appointments
with a diabetes consultant. During working hours there was at
least one diabetes specialist nurse available at the clinic to
receive phone calls from diabetes patients.
Follow-Up Assessments
Participants were sent the 3- and 9-month follow-up
questionnaires by postal mail with a prestamped envelope for
return. Each participant was given the opportunity to complete
their questionnaires with a researcher.
Health Care Professional and Engineer Training
All diabetes specialist nurses and consultants were provided
opportunities to learn how to use the MTH equipment and access
the MTH data via the Web interface. The MTH nurse received
training to remotely access and navigate participants’ electronic
medical records. The engineer was taken through the steps to
follow with participants and the content to cover in each MTH
training session.
Evaluation Measures
Overview
As recommended in the MRC guidance for complex
interventions [23], evaluation was designed to capture
information on both processes and outcomes. The quantitative
study data included clinical measures, self-reported
questionnaires administered to participants, logs/electronic notes
from the MTH app, and records kept by the technical support
team, MTH nurse, and engineer of contact with participants.
For self-reported data, standardized questionnaires with good
psychometric properties were used wherever possible—see
Table 1 for a summary of the data collected at the three time
points. Less commonly used and self-developed questionnaires
are described in greater detail below. Data from the qualitative
component included transcripts from audiotaped, semistructured
interviews conducted with intervention participants who agreed
to take part in this part of the evaluation.
Demographics
Data on age, gender, education, ethnicity, country of birth, and
whether English was spoken at home was collected.
Clinical Measures
Data on diabetes type, duration, medication, complications,
daily insulin dose, number of daily insulin injections, and Body
Mass Index (BMI) were taken from medical records.
Comorbidities were collected using self-reporting by
participants.
Familiarity With Mobile Phones
Familiarity with mobile phones was evaluated at the time of
recruitment by asking all participants who enrolled in the study
whether they owned a mobile phone (yes/no).
Primary Outcome Measure
The primary outcome measure, HbA1c, was collected from
medical records.
Secondary Outcome Measures
BP readings were recorded from medical records. Diabetes
self-management behaviors were measured using the Summary
of Diabetes Self-Care Activities (SDSCA) questionnaire [33],
which focuses on dietary behaviors, exercise, foot care, BG
testing, and cigarette smoking. An additional item asking
participants to specify their weekly frequency of self-monitoring
of BG levels was added to this assessment of behaviors. Generic
HRQoL was assessed using the Short Form-12 (SF12v2) with
a recall time of 4 weeks [34,35] and the Diabetes Health Profile
(DHP-18) was used as a disease-specific measure of HRQoL
[36]. Depression and anxiety were measured using the Center
for Epidemiologic Studies Short Depression Scale (CESD-10)
[37] and the State-Trait Anxiety Inventory (STAI-6) [38],
respectively. Data on the number of appointments attended
during the study at the diabetes clinic with diabetes specialist
nurses and consultants were collected from medical records.
Process Variables
Self-efficacy for managing health was measured using the
Health Education Impact Questionnaire (HeiQ, v3.0) [39], which
is used to investigate the impact of health interventions on
patient empowerment. It consists of eight subscales that can be
applied independently, two of which were used in the current
study. The self-monitoring and insight subscale assesses an
individual’s beliefs in his/her ability to monitor his/her health
and the physical and/or emotional responses that lead to
appropriate self-management. The skills and technique
acquisition subscale captures the beliefs an individual has in
his/her knowledge-based skills and techniques to self-manage
his/her health.
Disease-specific self-efficacy was assessed using the Insulin
Management Diabetes Self-Efficacy Scale (IMDSES) [40],
which consists of five subscales on general management, insulin
management, dietary management, exercise management, and
foot-care management. In line with clinical practice at the
diabetes unit where the study took place, references to urine
testing were removed from the questionnaire (eg, the question
“I cannot test my blood or urine when I am away from home”
became “I cannot test my blood when I am away from home”)
and an item on food exchange (ie, “I can correctly exchange
one food for another in the same food group”) was removed, as
this concept was not used in clinical practice or in diabetes
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education classes. Diabetes-specific illness beliefs were
measured using the Personal Models of Diabetes (PMD) scale
[41] consisting of two subscales focusing on beliefs related to
the seriousness of diabetes and treatment effectiveness.
Mobile Telehealth-Related Variables
Mobile Telehealth Self-Efficacy and Acceptability
In the absence of a currently available measure, a questionnaire
was developed to capture individuals’ beliefs about their ability
to operate the MTH equipment. To facilitate item generation,
a researcher used the MTH system for 1 week to identify the
different steps and skills required to transmit data and review
feedback. Ten items were generated in relation to data entry,
data transfer, menu navigation, display of graphical feedback,
and use of graphical feedback to identify BG patterns and make
adjustments to self-management behaviors. Each item of the
questionnaire begins with “I am confident that I am able to...”
The same 5-point Likert scale of another diabetes self-efficacy
measure [42] was used (1=No, definitely not, 2=Probably no,
3=Maybe yes, maybe no, 4=Yes, probably, 5=Yes, definitely).
Principal component analysis revealed one factor—higher scores
indicated greater self-efficacy to use the MTH equipment.
At the time of this study, there was no published and
psychometrically valid questionnaire to measure acceptability
of MTH, therefore, a questionnaire was developed to measure
acceptability. Item generation was guided by previous empirical
and theoretical work on user acceptance underlining the
importance of perceived usefulness, perceived ease of use, and
integration into life in determining acceptability and technology
usage. A principal component analysis was performed to
determine subscales, and three subscales—consisting of seven
items, 13 items, and seven items, respectively—were identified.
Participants were asked to rate their level of agreement with
each item using a 4-point Likert scale (0=Strongly disagree,
1=Somewhat disagree, 2=Somewhat agree, 3=Strongly agree).
In addition to this acceptability questionnaire, individual items
were included in the intervention group’s follow-up
questionnaires to assess perceived adequacy (one item asking
participants whether they would have liked more training) and
quality of the MTH training (one item), quality of the technical
support received over the phone (one item), frequency of usage
of the Web interface (one item), and perceived usefulness of
the Web interface (one item).
Participants’ Perceptions and Experiences of Use
Qualitative semistructured interviews were used to explore
participants’ perceptions of, and experiences using, MTH. An
interview guide was developed based on previous research and
areas of interest. It addressed several topics including initial
thoughts and expectations about MTH, use of the technology,
perceived impact on diabetes management, the relationship with
the MTH nurse, technical problems, and suggestions for
improvement. To limit the influence of social desirability on
responses, the relationship between the research team, the MTH
provider, and HCPs was clarified before the interview to
underline the independent nature of the evaluation. Participants
were also reminded that there were no correct answers to the
questions asked and that both negative and positive feedback
was valuable to help improve the MTH service. There are no
hard and fast rules about sample sizes in qualitative
enquiries—the required number of interviews remains a matter
of judgment and experience in assessing the quality of the data
collected against the purpose of the enquiry [43]. Recruiting
MTH participants for interviews continued until data saturation
occurred and no new themes emerged from the data on five
successive interviews. Previous qualitative TH studies included
fewer than 20 patient interviews [44,45], therefore, we expected
to conduct between 10 and 25 interviews.
Usage and Intervention Delivery
Data transmitted by intervention participants were collected as
they provide some indication of intervention receipt and
adherence. Data on contacts made between the MTH nurse,
technical support, the engineer, and intervention participants
were also collected. This included the number of contacts, the
medium used (ie, telephone, text message, in person), and
topic(s) discussed. To assess whether the intervention was
delivered as planned (ie, intervention fidelity), these data will
be compared to the fixed components of the intervention
protocol (ie, one training session for each intervention
participant, one introductory MTH call, six weekly educational
calls, and provision of technical support to solve technical
problems).
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Table 1. Assessment protocol and data collected at the three time points.
Data collection time pointAssessments and measurement tools used (where applicable)a
9 months3 monthsBaseline
✓Demographics
Clinical
✓Type and duration of diabetes, complications, comorbidities, medication type
✓✓✓HbA1c
✓✓BP, daily insulin dose
Psychological
✓✓✓Self-efficacy (IMDSES, HeiQ)
✓✓✓Illness beliefs (PMD)
Health outcomes
✓✓✓Self-management behaviors (SDSCA, weekly frequency blood testing)
✓✓✓Quality of life (SF36, DHP-18)
✓✓✓Psychological well-being (STAI-6, CESD-10)
Over 9 monthsNumber of appointments with diabetes nurses and consultants
MTH-related variables a
✓✓Acceptability of MTH (self-developed)
✓✓Self-efficacy to use MTH (self-developed)
✓Individual items on adequacy and quality of training, quality of technical support
✓✓Individual items on Web account usage and their perceived usefulness
Over 9 monthsMTH usage
Over 9 monthsIntervention fidelityb
Patient perceptions
✓Interview on MTH experience
aHbA1c: hemoglobin glycated; BP: blood pressure; IMDSES: Insulin Management Diabetes Self-Efficacy Scale; HeiQ: Health Education Impact
Questionnaire; PMD: Personal Models of Diabetes; SDSCA: Summary of Diabetes Self-Care Activities; SF36: Short Form Health Survey; DHP-18:
Diabetes Health Profile; STAI-6: State-Trait Anxiety Inventory-6; CESD-10: Center for Epidemiologic Studies Short Depression Scale-10; MTH:
Mobile Telehealth.
bAssessed in the intervention group only.
Data Analysis
The section below outlines the plans for data analysis which is
currently ongoing.
Quantitative Data Analysis
Effects of the Mobile Telehealth Intervention
For the primary analyses on the effectiveness of the intervention
on HbA1c, intention-to-treat analyses will be conducted using
hierarchical linear models as they account for the correlations
between repeated measurements. A significant Group x Time
interaction will be interpreted as evidence for differential
treatment effectiveness. Any demographic or clinical differences
at baseline will be adjusted for. These primary analyses will be
supplemented with secondary sensitivity analyses including
only those participants who actively transmitted MTH data
during the intervention period. Separate hierarchical linear
models will be used to evaluate the effects of the intervention
on secondary outcomes.
Mechanisms of Action of the Intervention
To evaluate whether diabetes self-efficacy and illness beliefs
act as mediators of change in the outcomes, bootstrapping for
mediation analyses using Preacher and Hayes macros [46] will
be conducted using residualized change scores for relevant
process and outcome variables.
Predictors of Usage
Hierarchical linear regressions will be conducted to examine
the incremental contribution of baseline predictors and
MTH-related variables in the prediction of MTH usage.
Telehealth-related variables considered as potential predictors
are based on the extended TAM model used in this study and
include perceived usefulness, ease of use, integration into life,
adequacy of training, and self-efficacy to use MTH.
Qualitative Data Analysis
A step-by-step guide for thematic analysis [47] will be followed
to analyze the interview data. Transcripts will first be read
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several times to become familiar with the data. Initial coding
of the interviews will follow. The data will then be organized
into themes and subthemes. The approach used will be inspired
by the constant comparative method used in grounded theory
and its combined elements of induction and deduction. This
hybrid approach allows for themes identified in previous
research to be considered during analysis, but also allows for
unexpected findings to emerge from the transcripts. To improve
the validity and reliability of the analysis, several researchers
with previous experience in MTH and/or qualitative data will
independently code some of the transcripts in order for themes
to be compared and/or will participate in discussions on the
extracted themes and supporting quotations.
Results
Overview
At this stage, data collection for both the quantitative and
qualitative components of this study has ended and data analysis
is ongoing. A total of 86 participants were enrolled into the
study. Out of 86 participants, 45 (52%) were randomized to the
intervention group and 36 (42%) to the control group. In this
paper, the data presented on MTH training sessions are relative
to the 44 intervention participants who received training. Data
presented on other MTH-related variables including MTH usage,
technical problems, and technical support experience are for
the 40 intervention participants who completed the 9-month
intervention.
Mobile Telehealth Training Sessions
Of the 45 participants allocated to the intervention group, 44
(98%) received training in the use of the MTH equipment (1
participant dropped out prior to finding out his allocation group).
The majority of trained intervention participants (37/44, 84%)
were able to transmit MTH data after the initial training session.
A small group of those trained (7/44, 16%) required a second
training session after experiencing ongoing difficulties in using
the equipment correctly. Compared to the 37 intervention
participants who only required one MTH training session—mean
age 56.4 years (SD 13.9), 22% (8/37) with no formal
education—these 7 participants were older and less
educated—mean age 67.5 years (SD 8.6), 43% (3/7) with no
formal education. These differences were not tested statistically
given the small number of participants involved. At the 3-month
follow-up, 17 (39%) of the 44 trained MTH participants reported
they would have liked to receive more training. When asked at
3 months about the quality of the training provided, 29 (66%)
of the 44 participants rated the quality of the training to be good
or very good, 10 (23%) rated the quality as adequate, and 2
(5%) as insufficient.
Mobile Telehealth Usage
Table 2 describes the number of times participants transferred
data during the trial, as well as the number of clinical readings
(ie, BG and BP readings) transmitted. The monthly number of
data transfers ranged from 0 to 126 and the median number of
transfers over 9 months was 63 (interquartile range [IQR] 242,
mean 173.9, SD 232.8). Of the 40 participants, 10 (25%) of
them were particularly active and transferred data between 202
and 778 times over 9 months. The monthly number of BG
readings transmitted ranged between 0 and 186, and the median
number of transfers over 9 months was 147 (IQR 337, mean
251.7, SD 278.0). In comparison to BG levels, BP was
monitored less frequently. The monthly number of BP readings
transmitted ranged between 0 and 66, and the median number
of BP readings transmitted over 9 months was 19 (IQR 31, mean
33.6, SD 53.3).
Table 3 displays the timing at which BG readings were
self-monitored.
Over the 9 months of the study, the median number of times
physical activity and insulin dose data were transferred was
11.5 (IQR 60) and 15.0 (IQR 83), respectively. This
corresponded to 40.8% (71/174) and 55.7% (97/174) of data
transfer occasions for physical activity and for insulin dose,
respectively. Weight information was rarely updated, with the
average number of updates over 9 months being 4.08 (SD 9.47)
times. A large proportion of participants (17/40, 43%) never
updated their weight information.
Table 2 indicates that for all measures of MTH, usage decreased
over time. The number of participants who did not transmit any
data increased over the duration of the trial as seen in Figure 2.
In the first month, all participants transmitted some MTH data.
By month 9, there were 14 out of 40 (35%) intervention
participants who did not transmit any MTH data.
Table 4 describes the different durations during which
participants ceased to transfer MTH data. The majority of
participants (22/40, 55%) transferred MTH data at least once
every month. For the remaining participants, the number of
months during which no data was transferred ranged from 1 to
8, with the majority of these participants transmitting data for
at least 5 of the 9 months.
The Web interface was available to all participants, however
only 5 (13%) and 6 (15%) of the 40 participants reported using
the MTH Web interface at the 3- and 9-month follow-ups,
respectively. The 5 participants that reported using the Web
account at 3 months also reported using it at 9 months. Of the
participants that used the Web interface at 3 months, 80% (4/5)
reported weekly usage at this time point. Of the participants
that used the Web interface at 9 months, 83% (5/6) reported
monthly usage at this time point. All participants who used the
Web account during the study reported that it was quite a bit
useful or very useful for visualizing graphical feedback.
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Table 2. Number of MTH data transfers and clinical readings transmitted during the 9-month study.
Number of BP readings, mean (SD)Number of BG readings, mean (SD)Number of data transfers, mean (SD)Month in trial
6.6 (10.5)31.2 (37.5)25.9 (34.2)Month 1
5.1 (9.1)31.4 (35.9)23.4 (30.9)Month 2
5.0 (9.6)31.2 (37.0)22.6 (31.5)Month 3
3.3 (5.8)27.9 (30.3)20.8 (28.0)Month 4
3.6 (6.0)26.2 (27.6)18.0 (20.5)Month 5
3.4 (4.5)26.7 (30.0)16.3 (25.8)Month 6
3.1 (5.7)24.6 (31.9)15.9 (26.0)Month 7
2.2 (4.2)28.6 (34.8)16.1 (27.3)Month 8
2.1 (3.9)24.6 (33.3)14.9 (25.2)Month 9
33.6 (53.3)251.7 (278.0)173.9 (232.8)Over 9 months
Table 3. Timing of self-monitoring of BG levels.
Number of BG readings (n=6959), n (%)Timing in relation to meal
1302 (18.71)>8 hours after a meala
1852 (26.61)2-4 hours after a meal
1512 (21.73)0-1 hour after a meal
969 (13.92)1-2 hours after a meal
1324 (19.03)4-8 hours after a meal
aBG readings taken >8 hours after a meal are likely to be fasting BGs.
Table 4. Length of time during which participants transferred no data during the study (n=40).
Proportion of MTH participants, n (%)Number of months during which no data was transferred
22 (55)0
2 (5)1
2 (5)2
6 (15)3
1 (3)4
2 (5)5
1 (3)6
1 (3)7
3 (8)8
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Figure 2. Number of participants per month who did not transmit mobile telehealth data during the study.
Mobile Telehealth Technical Problems
In total, 26 of the 40 participants (65%) experienced technical
problems during the study. The problems signaled were related
to data transmission between devices not working properly (13
occurrences), faulty equipment or problems with equipment
settings (10 occurrences), batteries on the mobile phone, BG
meter, or Bluetooth cradle running out (12 occurrences),
problems with the MTH app (3 occurrences), Web account
log-in problems (2 occurrences), and step-by-step assistance to
transmit MTH data required (8 occurrences). With the exception
of complaints about the battery life in the mobile phones (3
occurrences), all technical problems were successfully resolved
over the telephone or during a home visit scheduled within 1
week by the engineer on 6 occasions. Replacements for faulty
equipment were sent through postal mail. The MTH Web server
was down once during the study and repaired within 24 hours
by the technical support team. The majority (19/22, 73%) of
participants who reported having received technical support
over the phone at 3 months indicated it was of good or very
good quality.
Discussion
This study proposes a comprehensive assessment of an MTH
intervention for people with insulin-requiring diabetes. The
measurement of both clinical and patient-reported outcomes,
the use of a qualitative enquiry alongside an RCT, and the focus
on intervention delivery and usage still remain relatively
uncommon in complex interventions [20,24,48] and are included
in this study’s design and scope.
The preliminary data presented in this paper shows that the
initially targeted sample size of 248 was not reached. Several
reasons may help explain the low participation rate experienced
in this study, including poor attendance to clinic visits, changes
to the clinic patient discharge policy, and recruitment to other
TH trials at the diabetes unit where our recruitment took
place—the recruitment challenges experienced in this study
will be discussed in another paper. Such recruitment difficulties
are not uncommon in TH trials [49,50].
The early data presented on MTH usage in this paper clearly
indicates a decrease in MTH usage over time. Gradual declines
in usage have been observed in other TH studies [51-53]. A
positive interpretation of these declines over time proposed by
Larsen et al [52] is that participants may become less dependent
on MTH because of perceived improvements in the management
of their condition. Another possible explanation for the decrease
in usage over time is that the novelty of the new technology
wears off. Mobile phone network coverage is unlikely to have
influenced MTH usage in this study as coverage is generally
good in the UK and was not one of the problems the MTH
participants reported experiencing. Other technical problems
occurred, but our data showed they were dealt with successfully
and promptly by the technical support team. Making sure that
satisfactory technical support is provided in MTH studies is key
as technical problems can result in increased dropouts and
negative attitudes toward MTH [54].
The Web component of the MTH system remained unused by
a large majority of the intervention participants (34/40, 85%)
who completed this study. Participants were informed about
the possibility of using the Web accounts at the beginning of
the study. However, the MTH training sessions did not include
instructions relating to the MTH Web accounts, therefore, this
is likely to have contributed to their low use. Low Web account
usage in this study may also have been related to the lack of
Internet access in 63% of households in Newham [55], low
perceived need of access or usefulness of this data, disinterest,
or lack of awareness of the existence of a Web component.
Our study data showed that 39% (17/44) of MTH participants
reported they would have liked to receive more training. Other
studies have highlighted that some participants using TH may
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require a period of adjustment and familiarization with
technology, and that TH may be associated with
technology-related anxiety [56,57]. Together with our findings,
these studies suggest that some MTH users may benefit from
attending more than one training session. Of the 44 MTH
participants trained in our study, 7 (16%) were unable to use
the MTH equipment correctly and required a second training
session. Their characteristics suggested that factors such as age
and educational attainment may be related to training
requirements, however these relationships were not investigated
statistically, given the small number of participants concerned.
A small amount of research has examined factors related to TH
usage compliance [51,58], but there has been little emphasis on
predictors of MTH training needs. Larger studies should aim
to identify the individual characteristics associated with greater
MTH training needs, which could further help improve the
tailoring of MTH interventions.
This paper provides details of MTH usage data and other
information collected in this study on the quality and adequacy
of the MTH training sessions, and on the technical problems
experienced by MTH participants. Few MTH studies provide
sufficient information on technology usage, despite this being
an important measure of participants' receipt and adherence to
the intervention. The data presented in this paper are related to
intervention fidelity and are, therefore, crucial in considering
the internal validity of the study.
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